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Abstract
Normal human premenopausal cervical tissue has been used to derive primary cell populations and to establish ex vivo
organ culture systems to study infections with herpes simplex virus (HSV-1 or HSV-2) and human immunodeficiency virus
type 1 (HIV-1). Infection with either HSV-1 or HSV-2 rapidly induced multinuclear giant cell formation and widespread
damage in mucosal epithelial cells. Subsequent exposure of the damaged mucosal surfaces to HIV-1 revealed frequent co-
localization of HSV and HIV-1 antigens. The short-term organ culture system provides direct experimental support for the
epidemiological findings that pre-existing sexually transmitted infections, including primary and recurrent herpes virus
infections at mucosal surfaces, represent major risk factors for acquisition of primary HIV-1 infection. Epithelial damage in
combination with pre-existing inflammation, as described here for overtly normal human premenopausal cervix, creates a
highly susceptible environment for the initiation and establishment of primary HIV-1 infection in the sub-mucosa of the
cervical transformation zone.
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Introduction
The continuing worldwide HIV/AIDS epidemic is primarily
sustained by heterosexual transmission of HIV-1 [1,2,3]. Infectious
HIV-1 virions and/or HIV-1-infected cells are shed in semen,
vaginal secretions, or menstrual blood. Transfer of infectious
materials onto mucosal surfaces can result in transmission of
HIV-1 into uninfected individuals. Currently, more than half of all
newly acquired HIV-1 infections occur in young women following
heterosexual exposure. Despite intensive education campaigns and
ongoing efforts to develop successful prophylactic vaccination
strategies, there has only been modest global impact in reducing
current rates of HIV-1 transmission [4]. Animal models of
heterosexual HIV-1 transmission, based on vaginal infection of
female rhesus macaques, have shown that small foci of infected cells
arefirstdetected inproximitytomucosalsurfaces within3–7daysof
experimental exposure to SIV [5,6]. After transfer to the draining
lymph nodes, SIV is disseminated via the lymphatic system and the
circulation and systemic SIV infection is established in the next 7–
21 days [7,8]. These SIV/macaque results support the fundamental
conclusions that protective intervention for HIV-1 must be focused
at the site of exposure and must be immediately effective, if HIV-1
replication and spread are to be prevented in recently exposed
young women [3,9,10].
The mucosal surfaces of the lower regions of the female
reproductive tract are comprised of a multi-layered stratified
squamous epithelium lining the vaginal cavity and the ectocervix,
and a single layer of columnar epithelial cells lining the
endocervical canal. Multiple transfer mechanisms, involving
uptake by, or infection of macrophages [11,12] and Langerhans
cells [13], and transcytosis by epithelial cells [14] have been
proposed to explain how cell-free HIV-1 virions or cell-associated
infectious HIV-1 [15,16,17,18] traverse an intact mucosal surface
and interact with CD4+ T cells, the principal target cell supporting
active HIV-1 replication. We have previously demonstrated rapid
and extensive binding and penetration of both HIV-1 virions and
seminal cells in ex vivo human cervical organ cultures [19] and
realized that there may be large elements of variability impacting
on the initiation of HIV-1 infection in young women exposed to
infectious HIV-1 through heterosexual contacts [20]. From
epidemiological studies, it has been recognized that approximately
1 in 200 to 1 in 1000 potential male-to-female exposure events
actually results in HIV-1 transmission [21,22,23]. This relatively
low frequency of transmission can be explained by a continuum of
variables extending from the properties of the infectious inoculum
to the properties of the exposed mucosal surfaces. The presence of
pre-existing sexually transmitted infections (STI) is widely believed
to increase susceptibility to HIV-1 infection for exposed women,
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22638presumably by causing damage to mucosal surfaces and signaling
the recruitment of inflammatory cell infiltrates [24,25,26,27].
Several previous studies have described interactions between
herpes simplex virus (HSV-1 or HSV-2) and HIV-1
[28,29,30,31,32,33,34,35,36,37,38]. In the context of HIV-1
transmission, epithelial cell disruption caused by active herpes
virus infections or herpes virus reactivation may create mucosal
breaks and expose regions of sub-mucosa where primary HIV-1
infection could readily become established in CD4+ CCR5+ T
cells. The presence and distribution of CD4+ T cells as a
component of inflammatory infiltrates in the sub-mucosa reflects
previous and/or ongoing immunological stimulation. Active STIs,
including HSV infections, are known to increase the risk that
HIV-1 exposure will progress to primary HIV-1 infection. In this
ex vivo study, we have infected premenopausal cervical tissue by
sequential exposure to HSV-1 or HSV-2 followed by HIV-1
virions in seminal plasma, to develop more specific insight into the
cellular and molecular interactions whereby STIs may facilitate
the initiation of HIV-1 infection at mucosal surfaces in the normal
human female reproductive tract.
Results and Discussion
HSV Infection in Primary Epithelial Cells and Fibroblasts
In most natural HSV-1 and HSV-2 infections, initial virus
replication occurs in epithelial cells at mucosal surfaces [39] and
then virus rapidly spreads to sensory ganglia [40,41], where latent
infections become established in the trigeminal ganglia (oropha-
ryngeal HSV-1) or in the sacral ganglia (genital HSV-2). Changes
in sexual practices have led to increasing numbers of cases of
genital infections now being reported with HSV-1 [31,42].
Reactivation of latent HSV infection involves virus transport
within the sensory ganglia and can result in the (re)-appearance of
overt lesions at the original site(s) of infection, or at new sites
innervated by the same infected ganglia [40,41]. Although many
experimental HSV infections have used non-human target cells
such as immortalized African green monkey kidney cells (Vero
cells), some studies have been conducted in human cells, including
primary human keratinocytes [43]. HSV infections in epithelial
cells are cytolytic [44,45], as can readily be demonstrated by
experimental infection of primary cervical epithelial cells (Fig. 1
A–F). We have also noted cytolytic HSV infections in primary
cervical fibroblasts [46,47] (Fig. 1 G–I). Because of widespread
distribution of fibroblasts beneath the cervical epithelium, HSV
infection of tissue fibroblasts could have the effect of enlarging foci
of damage by providing a secondary target cell population for
HSV replication and facilitating HSV entry into peripheral nerve
endings [48].
HSV Infection in ex vivo Organ Culture
Epithelial cells in both the ectocervical epithelium and the
endocervical epithelium were found to be susceptible to infection
by herpes simplex viruses. Foci of infected cells, including aberrant
giant cells and multinucleated giant cells, were readily observed in
tissue pieces exposed to HSV-1 or HSV-2 and frequently
coincided with areas of obvious epithelial disorganization (Fig. 2).
The pathological changes in ex vivo HSV infections very closely
resembled changes observed in natural HSV lesions with the
characteristic appearance of multinucleated cells with nuclear
molding and chromatin margination. When HSV-infected cervical
tissue pieces were exposed to fluorescently labeled HIV-1 virions
(non-infectious HIV-GFP, [19]), HIV-1 virion binding was readily
visible in proximity to HSV-infected epithelial cells (data not
shown). These findings were fully consistent with our previous
results showing HIV-1 virion binding at sites of epithelial damage
when tissue surfaces were deliberately damaged prior to HIV-1
exposure [49].
HSV and HIV-1 Sequential Infections in Human Mucosal
Organ Cultures
The basic question of potential interaction between HSV and
HIV-1 at mucosal surfaces was examined by sequential ex vivo
infection of cervical tissue pieces with HSV-1 or HSV-2 followed
24–48 hours later by the addition of HIV-1 virions (dual tropic,
low passage patient isolate stock, HIV 96–480 [49]) in seminal
plasma. The inclusion of seminal plasma (the cell-free component
of normal human semen) in the HIV-1 infection protocol creates a
consistent surrogate inoculum that resembles semen from an HIV-
1-infected donor. After incubation for 3–5 days to allow the
establishment of primary HIV-1 infection, tissue pieces were fixed,
embedded in paraffin blocks and sectioned for analysis. Double
label immunofluorescence detection of HSV antigens with a rabbit
polyclonal antibody and HIV-1 p24 gag with a mouse monoclonal
antibody indicated accumulation of viral antigens within multi-
nucleated giant cell aggregates and/or within very closely adjacent
cells (Fig. 3 A–E). Tissue sections were also stained to reveal a
small inflammatory focus of CD4+ T cells, situated immediately
beneath the epithelial surface (Fig. 3 F, G). In this location, any
clustering of inflammatory cells may represent a highly susceptible
target site for infection wherein HSV-mediated disruption of the
surface epithelial layer allows direct access for infectious HIV-1 to
the CD4+ T cells in the sub-mucosa. During the progression of
HSV infection, cell fusion involving epithelial cells and CD4+ T
cells could then form the types of cell aggregates observed to
contain both HSV and HIV-1 antigens (Fig. 3A–E). Previous
studies ([19] and PJ Southern, unpublished results) have not
identified similar multinucleated giant cell forms in ex vivo organ
culture in the context of HIV-1 infection alone. Additional results
relating to the occurrence of pre-existing inflammation and the
conspicuous absence of multinucleated giant cells in un-manipu-
lated normal premenopausal cervical tissue are discussed below.
As a completely independent approach to examine HIV-1
virion binding and infection at epithelial surfaces damaged by
prior HSV infection, we used in situ hybridization to detect
cytoplasmic HIV-1 RNA as an indicator of productive HIV-1
infection. Clusters of silver grains indicating positive hybridization
signal were consistently observed in multinucleated giant cells
situated at disrupted epithelial surfaces (Fig. 4). Giant cells and
extensive disruption of the endocervical epithelium were not
observed in ex vivo organ cultures when the initial step of HSV
infection was omitted. This cumulative analysis of viral and
cellular antigens extends previous work [19] on the cellularity and
microarchitecture of cervical mucosal surfaces to highlight the
complexity of human mucosal surfaces and the interplay between
key parameters affecting susceptibility to microbial infections [20].
There is only limited published information dealing with the
susceptibility of human leukocytes to HSV infection but there is
evidence for direct HSV infection of CD4+ T cells
[50,51,52,53,54,55,56]. In natural infections and, recapitulated
here in organ culture experiments, there is the formal possibility
that CD4+ cells in the sub-mucosa (T cells, macrophages or
dendritic cells) may support dual infections with HSV and HIV-1.
However, given the finding of giant cell aggregates expressing both
HSV and HIV-1 antigens, the specific issue of dual HSV-HIV-1
infection, within the same cell, is not readily addressed in the
experiments reported here. Individual HSV and HIV-1 infections
can clearly occur in the absence of the other virus but the
independent findings of infected cell aggregates expressing
HSV and HIV Infections in Cervical Organ Culture
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signals from multinucleated giant cells provide direct experimental
support for a sequential process of HSV-induced damage leading
to increased susceptibility to primary HIV-1 infection. Although
we have not strictly demonstrated that HSV infections in ex vivo
organ cultures result in the release of infectious progeny virions,
detection of the late HSV protein, glycoprotein B (gB), strongly
suggests that the full temporal cascade of herpes virus gene
expression is occurring. Furthermore, the morphological appear-
ance of multinucleated giant cells is fully consistent with
productive and cytolytic HSV infection.
Pre-existing Inflammation in Cervical Tissue Samples
In order to develop some awareness of the extent of histological
variability that might typically be found in human premenopausal
cervix and as a validation of the causal association between acute
exogenous HSV infection and the abnormal morphological forms
documented in Figures 2, 3, 4, we conducted a retrospective
examination of overtly normal cervical samples that were fixed
immediately in the Southern laboratory (N=46; samples collected
over a four year period). Foci of inflammatory cells were
commonly observed beneath the stratified squamous epithelium
of the ectocervix, in proximity to the squamocolumnar transfor-
mation zone (23/41 samples with mild-severe inflammation; Figs. 5
and 6) and beneath the simple columnar epithelium of the
endocervix (18/39 samples with mild-severe inflammation Figs. 5
and 6). In addition, benign Nabothian cysts were commonly
observed in the squamocolumnar transformation zone (22/46
samples; Fig. 5). No multinucleated giant cell complexes were
observed in this survey of un-manipulated tissue samples that
resembled complexes consistently observed following experimental
infections with HSV-1 or HSV-2. However, we did not have
access to results for herpes serology evaluations or genital infection
diagnostics that might have been performed prior to surgery and
so the precise cause(s) of the observed inflammatory foci cannot
readily be determined.
The cervical transformation zone is defined by an abrupt
transition from the multi-layered ectocervical epithelium to the
single cell layer of the endocervical epithelium. In young adult
women, the transformation zone is usually located at the lower
opening of the endocervical canal (the cervical os). However,
around the time of menarche in adolescent girls, the transforma-
tion zone usually migrates outwards across the surface of the
cervix, well beyond the cervical os, to create a condition known as
cervical ectopy [57,58]. Ectopy is a normal, yet transiently altered
Figure 1. HSV infection of primary human cell populations.
Primary human cervical epithelial cells were propagated on transwell
membranes and then infected with 1610
5 plaque forming units (pfu) of
HSV-1 or HSV-2. Localized disruptions in the epithelial cell monolayers
were visible after 17 hours for HSV-2 infections and 24–36 hours for
HSV-1 infections. A, B: Phase contrast photomicrographs taken at
36 hours post HSV-2 infection. C: Phase contrast photomicrograph of
control uninfected primary cervical epithelial cells. D: Detection of HSV-
1 antigens by standard colorimetric immunohistochemistry: mouse
monoclonal anti-HSV-gB antibody. Brown stain reveals a focus of HSV-1-
infected cells at 21 hours post infection. E, F: Detection of HSV-1
antigens at 36 hours post infection by fluorescence microscopy; red:
mixture of mouse anti-HSV-ICP4 and mouse anti-HSV-gB monoclonal
antibodies, green: rabbit polyclonal anti-cytokeratin antibody, blue:
TOTO-3 nuclear stain. Inset in E shows uninfected primary epithelial
cells stained with the same antibody mixture. Note also that the lower
right corner of F contains a large region of uninfected cells with normal
epithelial morphology. Primary human fibroblasts were propagated on
glass chamber slides, infected with varying doses of HSV-2 then fixed
and processed for standard immunohistochemical detection with a
mouse monoclonal antibody directed against HSV-ICP4. G, H: Brown
stain reveals extensive HSV-2 infection at 24 hours post infection. Note
the presence of some uninfected cells in the upper left area of G and
the extensive morphological changes in the infected cell population
with 100-fold higher inoculum of HSV-2 in H. Essentially all of the cells
were infected with the 1610
5 pfu inoculum used in H. I: Control
population of uninfected primary cervical fibroblasts that were fixed
and processed in parallel with the anti-HSV-ICP4 antibody. Bars A–
C=250 mm; D=50 mm; E, F=100 mm; G–I=250 mm.
doi:10.1371/journal.pone.0022638.g001
HSV and HIV Infections in Cervical Organ Culture
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22638HSV and HIV Infections in Cervical Organ Culture
PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22638condition, with important implications for HIV-1 transmission.
Exposed areas of single layer columnar epithelium on the external
surface of the cervix may create a highly vulnerable location for
HIV-1 infection, especially with coincident inflammation of the
sub-mucosa. These changes may account for the particular
susceptibility to primary HIV-1 infection that has been observed
in adolescent girls [59]. Mild cervicitis is frequently observed in
sexually active young women [60,61,62,63] and pre-existing
inflammation together with any disruption to the integrity of the
epithelial barrier, as may be caused by microbial infections
[25,64,65] or physical trauma [66,67], could impact substantially
on the initiation of HIV-1 infection [20].
Immunohistochemical Analysis of Pre-existing
Inflammatory Cell Infiltrates
As the first step in understanding the cellular composition and
functional capabilities of inflammatory cell infiltrates detected in
human cervical tissue, we have used standard immunohistochem-
ical staining to document the presence of CD3, CD4 and
CD45RO-positive T cells. Foci of T cells were readily identified
in immediate proximity to the endocervical surface (Fig. 7;
representative images from the endocervix of 4 different patients)
and within and beneath the multilayered stratified squamous
epithelium of the ectocervix (not shown). Expression of CD45RO
was used as a marker for effector memory T cells located in
proximity to a mucosal surface and the presence of this cell
population was fully consistent with a recent or ongoing
inflammatory event that would have elicited the cellular
infiltration. In addition, neutrophils were frequently detected
within vessels, distributed throughout the sub-mucosa and trapped
in mucus in the endocervical canal (not shown). Because the
Institutional Review Board (IRB) approved protocol did not
include access to patient medical histories, we were unable to
identify specific conditions to account for the inflammatory
changes observed (Figs. 5, 6). However, cervicitis is commonly
observed in sexually active young women [60,61,62,63] and some
component of the inflammation may be triggered by direct contact
between seminal plasma and the mucosal surfaces [68].
The presence and distribution of leukocytes in the sub-mucosa
reflects extensive vascularization of the endocervix but this same
vascularization also provides an immediately accessible conduit
to transport HIV-1 infectivity away from sites of initial exposure
and primary infection. Based on the proximity of blood vessels
and the lymphatic drainage system to the luminal surface of the
endocervix and the finding of frequent microlesions in the
endocervical epithelium, HIV-1 virions or HIV-1-infected cells
in may only have to traverse a distance equivalent to 3–5 cell
diameters before encountering a vessel. Dissemination from the
portal of entry may therefore be occurring in an overlapping
time interval with the formation of sporadic foci of infection in
the sub-mucosa. This situation further highlights the protective
value of an intact mucosal barrier in impeding HIV-1
transmission and emphasizes the benefits of any available
strategies to diminish or eradicate other STIs that are known
to disrupt mucosal surfaces.
Concluding Remarks
The process of HSV-mediated epithelial disruption described
here, together with the potential for immediate HIV-1 replication
within CD4+ T cells situated in close proximity to the mucosal
surface [6,69] (Figs. 3 and 7), is likely to shift the HIV-1 balance
significantly from exposure to establishment of primary HIV-1
infection. Physical damage at epithelial surfaces in female
reproductive tissue can occur from either primary HSV infection
and/or from HSV reactivation, leading to disruption of the
mucosal surface and subsequent inflammation. Although recruit-
ment of inflammatory cells may not be fully reproduced in ex vivo
organ cultures, it is clear that mucosal damage can be induced in
model infections with HSV and that HIV-1 infection can be
established in pre-existing CD4+ T cell populations, resident in the
exposed tissue pieces [70,71,72,73]. Many STIs are known to be
associated with mucosal damage involving either epithelial
disruption and/or sub-mucosal inflammation, providing support
for the proposal that control of STIs, including HSV [74,75,76],
could have a beneficial impact on curtailing the spread of new
HIV-1 infections. Two epidemiological studies designed to explore
connections between HSV and HIV-1 infections [77,78] appeared
to reach conflicting conclusions but this could be explained by
differences in patient groups [79]. Amongst sexually active young
women, a clear connection was established between HSV-2, or
other genital infections, and the risk of acquisition of HIV-1 [78].
Several additional studies have attempted to resolve whether
acyclovir therapy to prevent HSV infection and suppress HSV
reactivation will have a protective benefit against HIV-1 infection
but the trials completed to date have not found any protective
effect of daily acyclovir therapy [80,81]. The overall interpretation
of these extensive clinical trials is further complicated by the
intriguing finding that phosphorylated acyclovir has an inhibitory
effect on HIV-1 replication [82,83]. Additional trials with
acyclovir may have to be conducted. However, at this point in
the HIV/AIDS epidemic, the combined recognition that minor
histological abnormalities are commonplace in overtly normal
premenopausal cervical tissue and that mucosal barrier integrity
may be readily disrupted, highlight additional complexities that
must be addressed in order to achieve comprehensive mucosal
protection against HIV-1 transmission.
Figure 2. Epithelial damage induced in HSV-infected cervical tissue. Histopathological changes induced in HSV-2-infected ectocervix include
areas of extensive epithelial damage with multinucleated giant cells. A, B: Hematoxylin and eosin (H&E) staining of 5 mm tissue sections; pieces of
ectocervix were infected with 1610
5 pfu of HSV-2 and fixed after 6 days in organ culture. Arrowheads in A indicate multinucleated giant cells – 7
giant cells are visible in ,500 mm of epithelial surface shown in the figure. C: Control section from an adjacent piece of ectocervix that was incubated
ex vivo for 6 days without exposure to HSV – some degeneration of the stratified squamous epithelium has occurred but no multinucleated giant
cells are present. D, E: Independent sections of ectocervix from the HSV-2-infected tissue shown in panels A and B, processed for standard
colorimetric immunohistochemical detection of viral antigens. D: Control antibody directed against HIV-1 p24 gag showing no positive signal (brown
stain) despite the presence of multinucleated giant cells. E: Rabbit polyclonal anti-HSV antibody showing strong positive signal (brown stain) in
multinucleated giant cells at the disrupted epithelial surface. F: Adjacent section from the HSV-2-infected ectocervix shown in A, B and D, E that was
analyzed by confocal fluorescence microscopy; green: rabbit polyclonal anti-HSV antibody, blue: TOTO-3 nuclear stain. G: Control, uninfected tissue
processed in parallel with F, using the same antibody mix and the same parameters for fluorescent image capture. H: H&E staining of a 5 mm tissue
section of HSV-2-infected endocervix, fixed after 7 days in organ culture. Note the extensive areas of epithelial damage and multinucleated giant cells
(arrows). Normal columnar endocervical epithelial cells are visible along the upper and lower surfaces of this tissue section. Bars A, B=100 mm;
C=250 mm; D–H=100 mm.
doi:10.1371/journal.pone.0022638.g002
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1+HIV-1. Tissue pieces were infected with 1610
5 pfu of HSV-1, incubated for 24 hours then infected with HIV-1 (virus equivalent to 20 pg of
p24gag) in normal seminal plasma and then incubated for an additional 120 hours. A, B: Giant cell aggregates visualized by confocal fluorescence
microscopy; green: rabbit polyclonal anti-HSV antibody, red: mouse monoclonal anti-HIV-1 p24 gag antibody with TSA enhancement, blue: TOTO-3
nuclear stain. Coincidence of green and red signals produces a yellowish-white color. C: Control uninfected tissue section processed in parallel with
the antibody combination used in A, B. Cell nuclei visualized with TOTO-3 nuclear stain. D, E: Detection of HSV-1 and HIV-1 antigens in close proximity
at the ectocervical surface; green: rabbit polyclonal anti-HSV antibody, red: mouse monoclonal anti-HIV-1 p24 gag antibody with TSA enhancement,
blue: TOTO-3 nuclear stain. Arrows indicate co-localization of HSV-1 and HIV-1 antigens in giant cell forms. F-G: Confocal fluorescence microscopy
with normal premenopausal endocervical tissue that was cultured for 6 days prior to fixation and processing; green: rabbit polyclonal anti-cytokeratin
antibody detecting epithelial cells, red: mouse monoclonal anti-CD4 antibody, with TSA enhancement, detecting a focus of CD4+ T cells located just
below the epithelial surface, blue: TOTO-3 nuclear stain. Bars A=25 mm; B=20 mm; C=50 mm; D=50 mm; E=20 mm; F=50 mm; G=25 mm.
doi:10.1371/journal.pone.0022638.g003
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HSV-2 and immunohistochemical detection of CD3 positive T cells. In situ hybridization to detect HIV-1 RNA visualized by the accumulation
of black silver grains; CD3 positive T cells visualized with DAB (brown stain); HSV-2 infected cells visualized in the form of multinucleated giant cells. In
this experiment, the anti-CD3 antibody detects either CD4+ or CD8+ T cells and both of these T cell populations can be found in proximity to the
luminal surfaces in the FRT (see Figure 7 also). A: HSV-2+HIV-1-infected tissue. B: Control tissue infected only with HSV-2, showing minimal
accumulation of silver grains. C, D: HSV-2+HIV-1-infected tissue. Inset in D shows a rare cell productively infected with HIV-1. Note that both the
density and number of silver grains are higher for the productively infected cell than observed for the multinucleated giant cells. Bar=25 mm.
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PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e22638Figure 5. Inflammation at the mucosal surface in human premenopausal cervix. A: H&E staining of the squamocolumnar cervical
transformation zone showing extensive inflammation and Nabothian cysts. Bar=500 mm. Based on the evaluation scheme used for inflammation, this
particular tissue was rated: Endocervix: Severe, multifocal, peri-epithelial inflammation. Ectocervix: Moderate, focal, stromal inflammation. In this
section, neutrophils, lymphocytes and plasma cells are the primary constituents of the cellular infiltrate. B: Higher magnification image of the
endocervical surface (area immediately below the arrowhead in panel A) showing the peri-epithelial location of the inflammatory cells. Bar=100 mm.
doi:10.1371/journal.pone.0022638.g005
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Cervical Organ Culture
Normal human premenopausal cervical tissue was obtained
within 1–2 hours of completion of the surgery from the BioNet
Tissue Procurement Facility at the University of Minnesota
Medical Center-Fairview. All tissue donors provided informed
written consent, prior to the initiation of surgery, to allow clinical
materials to be used for research purposes and all studies were
reviewed and approved by the IRB (Institutional Review Board:
Human Subjects Committee, Research Subjects’ Protection
Program, University of Minnesota). Hysterectomies were per-
formed as part of the surgical response to address varying
conditions including ovarian carcinoma, uterine fibroids and
menorrhagia; tissue from known pathological conditions involving
the cervix was not used for any of the ex vivo experiments presented
here. Some fresh tissue samples were immediately fixed in Streck
Tissue Fixative (STF; Streck, Omaha, NE), embedded in paraffin
and then processed for routine histological analysis. Cervical
inflammation was evaluated according to a mild/moderate/severe
and focal/multifocal/diffuse system previously described for
human prostate [84]. For both the endocervix and the
squamocolumnar cervical transformation zone, inflammation
was separately scored for stromal, peri-epithelial and intra-
epithelial regions and then condensed to achieve an overall
assessment of inflammation ranging from none to severe (Fig. 6).
The extent of inflammation was defined as follows:
Minimal: 1–5 inflammatory foci involving ,10–20 cells
Mild: 1–5 inflammatory foci involving ,20–50 cells
Moderate: 5–10 inflammatory foci involving ,20–50 cells and/
or foci involving ,100–200 cells
Severe: diffuse inflammatory foci involving .200 cells.
Tissue samples for experimental infections were either sur-
rounded in agarose/medium wells to leave the mucosal surface
exposed or tissue pieces were placed on collagen sponges
(Gelfoam, Upjohn/Pharmacia, Kalamazoo, MI), as previously
described [19]. Tissue pieces were infected by submersion under a
thin film of medium containing the virus inoculum in agarose/
medium wells or the virus inoculum was slowly dripped onto the
tissue surface from a micropipet tip. In either culture system, tissue
surfaces were kept moist by periodic addition of fresh medium,
with the effect of washing away any residual unbound virus.
Primary Cell Culture
Primary populations of cervical epithelial cells and fibroblasts
were derived by selective removal of the epithelial surfaces
Figure 6. Summary of inflammation observed in the ectocervix in proximity to the squamocolumnar cervical transformation zone
and in the endocervix of normal premenopausal women.
doi:10.1371/journal.pone.0022638.g006
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scalpel blades. In some experiments, epithelial cells were
preferentially expanded on 0.4 mm cell culture inserts (transwells,
0.4 mm pore size; Becton Dickinson Labware, Franklin Lakes,
NJ) so that the membrane surfaces could be wet on both sides
with complete culture medium (RPMI 1640 basal medium
supplemented with 10% heat-inactivated fetal calf serum and a
standard antibiotic and antifungal mixture - 200units/ml
penicillin, 200units/ml streptomycin, 500 ng/ml amphotericin
B [Antibiotic-Antimycotic #15240-062; Invitrogen, Carlsbad
CA] [19]). Primary cervical fibroblast populations were readily
derived from disrupted tissues pieces and these populations could
be maintained in continuous culture for 6–10 weeks, using
conventional protocols to manipulate adherent cell populations.
Figure 7. Characterization of inflammatory cell populations in normal human premenopausal endocervix. 5 mm tissue sections were
incubated with the primary monoclonal antibodies listed below. Positive signal (brown stain) was revealed with biotinylated secondary antibodies
and streptavidin-peroxidase conjugates. Slides were counterstained lightly with hematoxylin. Images are representative of staining patterns observed
with 15–20 independent tissue samples. A: CD3. B: CD4. C: CD45RO. D: Control Primary Antibody. A–D from Cervix#1; Bar=100 mm. E: CD3. F: CD4. G:
CD45RO. H: Control Primary Antibody. E–H from Cervix#2; Bar=50 mm. I: CD3. J: CD4. I–J from Cervix#3; Bar=50 mm. K: CD3. L: Claudin-4, detecting
tight junctions between columnar epithelial cells. K–L from Cervix#4; Bar=50 mm.
doi:10.1371/journal.pone.0022638.g007
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morphology (cuboidal epithelial cells; elongated spindle fibro-
blasts) and selective high-level expression of cytokeratins by
epithelial cells and vimentin by fibroblasts. Primary cell
populations were infected either on transwell membranes or
after seeding cells onto glass chamber slides. After incubation,
washing and fixation, viral and cellular antigens were detected
by standard procedures for colorimetric immunohistochemistry
or immunofluorescence.
Viruses
A dual-tropic primary patient isolate of HIV-1 (HIV 96–480;
virus stock 200 pg/ml based on p24gag content) was used for all
experiments involving infectious HIV-1 [49]. Virion binding
studies were performed with non-infectious fluorescently labeled
virus particles (HIV-GFP) [19,49]. Cell-free tissue culture
supernatant stocks of laboratory strains of HSV-1 (KOS1.1)
and HSV-2 (ATCC Strain G) were prepared by infection of Vero
cell monolayers and harvested when extensive cytopathic effects
(cpe) were visible in the target Vero cell monolayers. HSV-1 and
HSV-2 stocks were used interchangeably for all infections with
essentially equivalent results for each virus although HSV-2
infections progressed more rapidly and resulted in more extensive
cytopathology. Details in the figure legends identify the particular
virus used and the duration of infection. The results shown for
HSV infections of primary cell populations, HSV infections of
tissue pieces and HSV+HIV-1 dual infections are all represen-
tative of independent infections with tissue from 3–5 different
donors.
Antibodies
Primary antibodies to detect cellular or viral antigens were used
as described previously [49,72]. Antibodies were obtained as
follows:
HSV glycoprotein B (gB; MAb Catalog #13-120-100; Ad-
vanced Biotechnologies Incorporated, Columbia, MD); HSV
infected cell protein 4 (ICP4; MAb Clone H1114; Rumbaugh-
Goodwin Institute for Cancer Research, Plantation, FL); HSV-1
(Rabbit polyclonal Ab#084P; BioGenex, San Ramon CA); HSV-
2 (Rabbit polyclonal Ab#085P; BioGenex); HIV-1 p24 (MAb
Clone Kal-1; Dako, Carpinteria, CA); cytokeratins: (Rabbit
polyclonal Catalog #Z062201; Dako); CD3 (Rabbit polyclonal
Catalog #A045229; Dako); CD4 (MAb Clone 1F6; Zymed
Laboratories, South San Francisco, CA); CD45RO (MAb Clone
UCHL-1; BioGenex); claudin 4 (MAb Clone 3E2C1: Zymed).
Immunohistochemistry and Immunofluorescence
Secondary antibodies were either conjugated to biotin for
colorimetric detection with a streptavidin-biotin signal amplifica-
tion system (ABC System, Vector Laboratories, Burlingame, CA)
based on horse radish peroxidase and DAB or fluorescent signals
were visualized using cy3- and cy5-secondary antibody conjugates
(Jackson ImmunoResearch Laboratories, West Grove, PA).
Tyramide signal amplification (TSA) was performed exactly as
recommended by the manufacturer of the reagents (Renaissance
TSA Fluorescence Systems; Perkin Elmer, Boston, MA).
In situ Hybridization and Immunohistochemical Double
Labeling
35S-labeled antisense riboprobe was prepared by in vitro
transcription of the SacI linearized plasmid construct containing
a 5256 bp fragment of the HIV-1 NL4-3 clone (pNL4-3,
generously provided by Dr. Ashley Haase) [85] using T7 RNA
polymerase in the presence of
35S-rUTP (MP Biomedicals, Solon,
OH). After transcription, template plasmid DNA was digested by
the addition of RQ1 DNAse (Promega). Labeled RNA probes
(,700 bases) were recovered after DNAse treatment, partial
alkaline hydolysis and removal of unincorporated nucleotides
using silica affinity membranes (QIAquick Nucleotide Removal
Kit, Qiagen, Valencia, CA). Combined in situ hybridization and
imunohistochemistry was used to detect HIV-1 cytoplasmic RNA
and cell antigens on 5 mm deparaffinized tissue sections using
previously published methods [5,72]. Slides were briefly counter-
stained by dipping in Harris hematoxylin (Fisher), dehydrated and
mounted with Permount mounting medium (Fisher).
Confocal Microscopy
Primary data sets were collected using a BioRad 1024 laser
scanning confocal microscope and then processed using Image J,
AMIRA and Photoshop software programs.
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